Clinical Trial Update: Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the efficacy and safety of nateglinide in renal transplant recipients with posttransplant diabetes mellitus or impaired glucose toleranc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Glucose Tolerance
• Posttransplant Diabetes Mellitus

Drugs mentioned

• Starlix (nateglinide)

Snippet

Sponsor: University of Oslo School of Pharmacy | Conditions: Renal Transplant Recipients, Posttransplant Diabetes Mellitus | Phase 4 | Status: COMPLETED